The goal of this research is to collect Tau PET imaging in cognitively normal older adults and
patients with Mild Cognitive Impairment (MCI) in the NACC study, to
determine relationship to clinical, cognitive, and other biomarker data.
Findings from this study will likely provide insight into the
mechanisms and distinctions of age-related cognitive decline and that of
Only those participants enrolled in the NACC cohort (protocol 068200) who have received a consensus conference designation
of Cognitively Normal or MCI, are eligible to participate in this protocol.